Evidence map›Paper›PMID 11172020›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2001

The role of zinc in the binding of killer cell Ig-like receptors to class I MHC proteins.

M Valés-Gómez, R A Erskine, M P Deacon, J L Strominger, H T Reyburn

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Group AScience immunology · 2023
    Article
  3. Review
  4. Review
  5. Article
  6. Zinc in innate and adaptive tumor immunity.Journal of translational medicine · 2010
    Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Disulfide bond-mediated dimerization of HLA-G on the cell surface.Proceedings of the National Academy of Sciences of the United States of America · 2002
    Article
  12. Article
  13. Article
  14. Signaling at the inhibitory natural killer cell immune synapse regulates lipid raft polarization but not class I MHC clustering.Proceedings of the National Academy of Sciences of the United States of America · 2001
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

M Valés-GómezDepartment of Pathology, Cambridge University, Tennis Court Road, Cambridge CB2 1QP, United Kingdom.
R A Erskine
M P Deacon
J L Strominger
H T Reyburn

Funding

CHEMISTRY AND BIOLOGY OF LYMPHOCYTESR35CA047554 · NCI · HARVARD UNIVERSITY · PI STROMINGER, JACK L · 1988 to 2001
$4.7M
NCI NIH HHS CA-47554Wellcome Trust
6 · The paper itself

Abstract

The binding of killer cell Ig-like Receptors (KIR) to their Class I MHC ligands was shown previously to be characterized by extremely rapid association and dissociation rate constants. During experiments to investigate the biochemistry of receptor-ligand binding in more detail, the kinetic parameters of the interaction were observed to alter dramatically in the presence of Zn(2+) but not other divalent cations. The basis of this phenomenon is Zn(2+)-induced multimerization of the KIR molecules as demonstrated by BIAcore, analytical ultracentrifugation, and chemical cross-linking experiments. Zn(2+)-dependent multimerization of KIR may be critical for formation of the clusters of KIR and HLA-C molecules, the "natural killer (NK) cell immune synapse," observed at the site of contact between the NK cell and target cell.

Indexed as

Histocompatibility Antigens Class IHLA-C AntigensHumansKiller Cells, NaturalKineticsMagnesiumReceptors, ImmunologicReceptors, KIRZincHistocompatibility Antigens Class IHLA-C AntigensMagnesiumReceptors, ImmunologicReceptors, KIRZinc

Identifiers

PMID11172020
PMCPMC29326

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.